首页> 外国专利> TETHERED INTERLEUKIN-2 TO ITS RECEPTOR IL-2RBETA, A PLATFORM TO ENHANCE NATURAL KILLER AND REGULATORY T CELL ACTIVITY

TETHERED INTERLEUKIN-2 TO ITS RECEPTOR IL-2RBETA, A PLATFORM TO ENHANCE NATURAL KILLER AND REGULATORY T CELL ACTIVITY

机译:四联体白介素2与其受体IL-2RBETA结合,该平台可增强自然杀手和调节性T细胞活性

摘要

Fusion proteins comprising IL2 and IL2Rβ (e.g., CIRB), IL2, IL2Rβ and IL21R (e.g., CIRB21), and/or comprising IL2, IL2Rβ, and CD28 (e.g., CIRB28); natural killer (NK) cells that express the fusion proteins and methods of use thereof, e.g., to treat subjects with cancer; and regulatory T cells (T-regs) that express a fusion protein comprising IL2, IL2Rβ, and CD28 and methods of use thereof, e.g., to treat subjects with autoimmune disease or GVHD.
机译:包含IL2和IL2Rβ(例如CIRB),IL2,IL2Rβ和IL21R(例如CIRB21)和/或包含IL2,IL2Rβ和CD28(例如CIRB28)的融合蛋白;表达融合蛋白的天然杀伤(NK)细胞及其使用方法,例如用于治疗患有癌症的受试者;以及表达包含IL2,IL2Rβ和CD28的融合蛋白的调节性T细胞(T-regs)及其使用方法,例如,用于治疗自身免疫性疾病或GVHD的受试者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号